Recommendations for management of Chagas disease in organ and hematopoietic tissue transplantation programs in nonendemic areas

Imagem de Miniatura
Arquivos
art_PINAZO_Recommendations_for_management_of_Chagas_disease_in_organ_2011.PDF (216.02 KB)
Citações na Scopus
84
Tipo de produção
article
Data de publicação
2011
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
PINAZO, Maria-Jesus
MIRANDA, Blanca
RODRIGUEZ-VILLAR, Camino
ALTCLAS, Javier
SERRA, Merce Brunet
GARCIA-OTERO, Elias Canas
ALMEIDA, Eros Antonio de
GARCIA, Manuel de la Mata
GASCON, Joaquim
RODRIGUEZ, Magdalena Garcia
Citação
TRANSPLANTATION REVIEWS, v.25, n.3, p.91-101, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The substantial immigration into Spain from endemic areas of Chagas disease such as Latin America has increased the number of potential donors of organs and tissues. In addition, an increasing number of patients with advanced Chagas heart disease may eventually be eligible to receive a heart transplant, a universally accepted therapeutic strategy for the advanced stages of this disease. Therefore, it is necessary to establish protocols for disease management. This document is intended to establish the guidelines to be followed when a potential donor or a tissue or organ recipient is potentially affected by Chagas disease and summarizes the action criteria against the possibility of Chagas disease transmission through the donation of organs, tissues, or hematopoietic stem cells and aims to help professionals working in this field. A single registry of transplants in Trypanosoma cruzi infected donors and/or recipients will provide and disseminate experience in this area, which has shown a low recorded incidence to date.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/23057
Referências
  1. Altclas J, 1999, TRANSPL INFECT DIS, V1, P135
  2. Amato Neto V, 1992, REV HOSP CLIN FAC ME, V47, P92
  3. DELCASTILLO M, 1990, AM J MED, V88, P693, DOI 10.1016/0002-9343(90)90544-N
  4. Otani MM, 2009, TRANSFUSION, V49, P1076, DOI 10.1111/j.1537-2995.2009.02107.x
  5. Bestetti RB, 2009, J CARD FAIL, V15, P249, DOI 10.1016/j.cardfail.2008.10.023
  6. Altclas J, 2005, BONE MARROW TRANSPL, V36, P123, DOI 10.1038/sj.bmt.1705006
  7. Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023
  8. Lipp HP, 2008, MYCOSES, V51, P7, DOI 10.1111/j.1439-0507.2008.01523.x
  9. Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407
  10. Bocchi EA, 2001, ANN THORAC SURG, V71, P1833, DOI 10.1016/S0003-4975(01)02587-5
  11. Urbina JA, 2002, CURR PHARM DESIGN, V8, P287, DOI 10.2174/1381612023396177
  12. Fores R, 2007, BONE MARROW TRANSPL, V39, P127, DOI 10.1038/sj.bmt.1705551
  13. Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019
  14. Schofield CJ, 2006, TRENDS PARASITOL, V22, P583, DOI 10.1016/j.pt.2006.09.011
  15. Ferraz ML, 2007, ANTIMICROB AGENTS CH, V51, P1359, DOI 10.1128/AAC.01170-06
  16. Pinazo MJ, 2010, AM J TROP MED HYG, V82, P583, DOI 10.4269/ajtmh.2010.09-0620
  17. [Anonymous], 2002, WHO TECHN REP SER
  18. Portela-Lindoso AAB, 2003, REV SAUDE PUBL, V37, P107, DOI 10.1590/S0034-89102003000100016
  19. Fernandes CD, 2009, MEM I OSWALDO CRUZ, V104, P27, DOI 10.1590/S0074-02762009000100004
  20. Maldonado C, 2004, J HEART LUNG TRANSPL, V23, P1345, DOI 10.1016/j.healun.2003.09.027
  21. Kantola T, 2000, EUR J CLIN PHARMACOL, V56, P225, DOI 10.1007/s002280000127
  22. Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629
  23. Riarte A, 1999, CLIN INFECT DIS, V29, P561
  24. Kun H, 2009, CLIN INFECT DIS, V48, P1534, DOI 10.1086/598931
  25. Jackson Y, 2009, EMERG INFECT DIS, V15, P601, DOI 10.3201/eid1504.080438
  26. deCarvalho VB, 1996, CIRCULATION, V94, P1815
  27. D'Albuquerque LAC, 2007, AM J TRANSPLANT, V7, P680, DOI 10.1111/j.1600-6143.2007.01663.x
  28. Munoz J, 2007, T ROY SOC TROP MED H, V101, P1161, DOI 10.1016/j.trstmh.2007.06.011
  29. Diez M, 2007, AM J TRANSPLANT, V7, P1633, DOI 10.1111/j.1600-6143.2007.01820.x
  30. Riera C, 2006, AM J TROP MED HYG, V75, P1078
  31. Bocchi EA, 1996, ANN THORAC SURG, V61, P1727, DOI 10.1016/0003-4975(96)00141-5
  32. Bestetti RB, 2007, TRANSPLANTATION, V84, P441, DOI 10.1097/01.tp.0000277526.68754.02
  33. Viotti R, 2006, ANN INTERN MED, V144, P724
  34. Moton A, 2009, CURR MED RES OPIN, V25, P701, DOI 10.1185/03007990802644209
  35. Campos SV, 2008, J HEART LUNG TRANSPL, V27, P597, DOI 10.1016/j.healun.2008.02.017
  36. Altclas JD, 2008, JAMA-J AM MED ASSOC, V299, P1134, DOI 10.1001/jama.299.10.1134-a
  37. Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X
  38. Pinazo MJ, 2010, GASTROENT HEPAT-BARC, V33, P191, DOI 10.1016/j.gastrohep.2009.07.009
  39. Piron M, 2008, TRANSFUSION, V48, P1862, DOI 10.1111/j.1537-2995.2008.01789.x
  40. Neuvonen PJ, 1998, CLIN PHARMACOL THER, V63, P332, DOI 10.1016/S0009-9236(98)90165-5
  41. DOCAMPO R, 1990, CHEM-BIOL INTERACT, V73, P1, DOI 10.1016/0009-2797(90)90106-W
  42. Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
  43. Bacal F, 2005, AM J TRANSPLANT, V5, P2017, DOI 10.1111/j.1600-6143.2005.00975.x
  44. Barcan L, 2005, LIVER TRANSPLANT, V11, P1112, DOI 10.1002/lt.20522
  45. Bocchi EA, 1998, J HEART LUNG TRANSPL, V17, P399
  46. BOCCHI EA, 1993, TRANSPLANT P, V25, P1329
  47. Castro C, 2005, REV SOC BRAS MED TRO, V38, P1, DOI 10.1590/S0037-86822005000100001
  48. Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P210
  49. Garcia SC, 2005, REV SOC BRAS MED TRO, V38, P61
  50. Dejour Salamanca D, 2009, Bull Soc Pathol Exot, V102, P285
  51. Dictar M, 1998, BONE MARROW TRANSPL, V21, P391, DOI 10.1038/sj.bmt.1701107
  52. Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419
  53. Ferreira M. S., 1997, CLIN TERAPEUTICA DOE, P365
  54. Fiorelli AI, 2005, TRANSPLANT P, V37, P2793, DOI 10.1016/j.transproceed.2005.05.038
  55. Flores-Chavez M, 2008, ENF EMERG S1, V10, P47
  56. Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019
  57. Gascon J, 2007, REV ESP CARDIOL, V60, P285, DOI 10.1016/S1885-5857(07)60153-4
  58. Gascon J, 2005, MED CLIN-BARCELONA, V125, P230, DOI 10.1157/13077386
  59. Geist MJP, 2007, ANTIMICROB AGENTS CH, V51, P3455, DOI 10.1128/AAC.00579-07
  60. Godoy HL, 2010, J HEART LUNG TRANSPL, V29, P286, DOI 10.1016/j.healun.2009.08.006
  61. Guerri-Guttenberg RA, 2008, EUR HEART J, V29, P2587, DOI 10.1093/eurheartj/ehn424
  62. Jackson Y, 2009, ENF EMERG, V11, P49
  63. Leather HL, 2004, BONE MARROW TRANSPL, V33, P137, DOI 10.1038/sj.bmt.1704316
  64. Lescurc X, 2008, EMERG INFECT DIS, V14, P644
  65. Liu P, 2008, J CLIN PHARMACOL, V48, P73, DOI 10.1177/0091270007309703
  66. Liu P, 2007, ANTIMICROB AGENTS CH, V51, P3617, DOI 10.1128/AAC.00526-07
  67. Livramento J A, 1989, Arq Neuropsiquiatr, V47, P332
  68. Matcsanz R, 2007, PROCESO DONACION TRA
  69. Mediavilla A, 2008, FARMACOLOGIA HUMANA, P1301
  70. Munoz J, 2009, ACTA TROP, V111, P51, DOI 10.1016/j.actatropica.2009.02.005
  71. PAULOS C, 1989, INT J CLIN PHARM TH, V27, P454
  72. Perez de Pedro I., 2008, ENF EMERG S1, V10, P14
  73. Pinto Dias J C., 1995, ARQ BRAS CARDIOL, V65, P359
  74. Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2
  75. Riarte A, 2000, MEDICINA BUENOS A S3, V60, P31
  76. ROCHA A, 1994, AM J TROP MED HYG, V50, P261
  77. Salomone OA, 2000, AM J CARDIOL, V85, P1274, DOI 10.1016/S0002-9149(00)00747-5
  78. Souza FF, 2008, TRANSPL P, V40, P875, DOI 10.1016/j.transproceed.2008.02.032
  79. STOLF NAG, 1987, J HEART TRANSPLANT, V6, P307
  80. STROUT RG, 1962, J PARASITOL, V48, P100, DOI 10.2307/3275421
  81. Todd JR, 2001, AIDS PATIENT CARE ST, V15, P505, DOI 10.1089/108729101753205667
  82. Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - LIM/48